(Q44410802)

2 December 2017

Plasma 3-nitrotyrosine and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide (English)

1 reference

2 December 2017

Plasma 3-NITROTYROSINE and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide (English)

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(03)00063-7

bronchopulmonary dysplasia

26 December 2023

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(03)00063-7

26 December 2023

author name string

Jason Christie

3

1 reference

2 December 2017

John Althaus

5

1 reference

2 December 2017

Keri Schmidt

6

1 reference

2 December 2017

Harry Ischiropoulos

8

1 reference

2 December 2017

Scott A. Lorch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706495

26 December 2023

Beverly A. Banks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706495

26 December 2023

Jeffrey D. Merrill

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706495

26 December 2023

Philip L. Ballard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706495

26 December 2023

Roberta A. Ballard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706495

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706495

26 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0891584903000637?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(03)00063-7

https://api.elsevier.com/content/article/PII:S0891584903000637?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(03)00063-7

Free Radical Biology and Medicine

26 December 2023

published in

1 reference

2 December 2017

34

1 reference

2 December 2017

9

1 reference

2 December 2017

1146-1152

1 reference

Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Neutrophils convert tyrosyl residues in albumin to chlorotyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Human neutrophils employ chlorine gas as an oxidant during phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: dependence on cell size, time from birth, insulin-like growth factor I, and auto-activation of protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Pulmonary hypertension in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

The impact of confounder selection criteria on effect estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-tr

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2803%2900063-7

7 January 2021

2

1 reference

https://api.crossref.org/works/10.1016/S0891-5849(03)00063-7

26 December 2023

Identifiers

1 reference

2 December 2017

1 reference